Autolus Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Autolus Therapeutics plc (AUTL) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Sep 2018
Current Assets
Cash and Cash Equivalents0.230.240.380.310.150.210.25
Short-Term Investments0.360.000.000.000.000.000.00
Cash & Short-Term Investments0.590.240.380.310.150.210.25
Accounts Receivable0.050.020.030.030.030.000.01
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.020.010.010.000.010.000.00
Total Current Assets0.660.280.430.350.200.250.26
Non-Current Assets
Property, Plant & Equipment (Net)0.110.100.060.050.090.020.01
Intangible Assets0.010.000.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.010.000.00
Total Non-Current Assets0.120.100.060.060.060.030.01
Total Assets0.780.380.490.410.290.300.27
Current Liabilities
Accounts Payable0.000.000.000.020.000.020.01
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.050.040.040.020.030.000.00
Other Current Liabilities0.000.000.000.000.000.000.00
Total Current Liabilities0.060.040.050.030.030.020.02
Non-Current Liabilities
Long-Term Debt0.240.170.130.020.050.020.00
Other Non-Current Liabilities0.000.000.000.000.000.000.00
Total Non-Current Liabilities0.290.220.150.060.050.020.00
Total Liabilities0.360.260.190.090.080.050.02
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.10-0.88-0.67-0.52-0.38-0.24-0.09
Accumulated Other Comprehensive Income-0.03-0.03-0.04-0.01-0.01-0.01-0.01
Additional Paid-in Capital1.561.021.010.840.600.500.36
Shares Outstanding0.270.170.170.090.000.000.00
Total Stockholders' Equity0.430.110.300.310.210.250.26
Total Liabilities & Equity0.780.380.490.410.290.300.27